GeoVax Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial
February 06, 2020 09:00 ET
|
GeoVax, Inc.
Company Comments on NIH/NIAID Discontinuance of Sanofi/GSK HVTN 702 Trial ATLANTA, GA, Feb. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTC: GOVX), a biotechnology...
GeoVax Observes 2019 World AIDS Day
December 02, 2019 09:00 ET
|
GeoVax, Inc.
Developing Multiple Strategies Toward Ending the HIV/AIDS Epidemic ATLANTA, GA, Dec. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTC: GOVX), a biotechnology company...
GeoVax Presents HIV Vaccine Study Data
July 24, 2019 09:00 ET
|
GeoVax, Inc.
Presentation Made at the 10th International AIDS Society Conference on HIV Science ATLANTA, GA, July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a...
GeoVax CEO David Dodd Responds to President Trump’s State of the Union Message
February 06, 2019 10:11 ET
|
GeoVax, Inc.
Applauding HIV Elimination Goals and Encouraging More Resources Toward Vaccine Development ATLANTA, GA, Feb. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX)....
GeoVax Observes 2018 World AIDS Day
December 03, 2018 09:00 ET
|
GeoVax, Inc.
Recognizing the Importance of Partnerships ATLANTA, GA, Dec. 03, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE– GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines,...
GeoVax Provides Update on HIV Clinical Trials Program
November 28, 2018 09:00 ET
|
GeoVax, Inc.
Innovative Combination Vaccine Advancing in Clinical Trials ATLANTA, GA, Nov. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company...
GeoVax Announces Further Positive Results of its HIV Preventive Vaccine Program at International HIV Research Conference
October 24, 2018 11:00 ET
|
GeoVax, Inc.
Booster Vaccination After ~7 Years Resulted in 600-fold Increase in Antibody Response ATLANTA, GA, Oct. 24, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a...
GeoVax Announces Publication of HIV Vaccines Review
October 22, 2018 09:00 ET
|
GeoVax, Inc.
Comprehensive Review Published in the Peer-Reviewed Journal, Clinical Pharmacology and Therapeutics ATLANTA, GA, Oct. 22, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB:...
GeoVax Observes National Gay Men’s HIV/AIDS Awareness Day
September 27, 2018 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, Sept. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today is observing National Gay Men’s HIV/AIDS...
HIV Vaccine Awareness Day Recognizes Global Efforts
May 21, 2015 11:31 ET
|
International Centre for Infectious Disease
WINNIPEG, May 21, 2015 (GLOBE NEWSWIRE) -- Recent scientific discoveries in HIV illustrate the need for partnerships and collaboration in the effort to develop a safe and effective HIV vaccine. But...